OncoVista Innovative Therapies, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OVIT research report →
About the company
OncoVista Innovative Therapies, Inc. does not have significant business. Previously, it engaged in development of targeted anticancer therapies by utilizing tumor-associated biomarkers.
- CEO
- Alexander L. Weis
- IPO
- 2007
- Employees
- 2
- HQ
- San Antonio, TX, US
Price Chart
- Market Cap
- $2.36K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -0.08
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 57.94%
- ROIC
- 53.54%
- Revenue
- $0 · 0.00%
- Net Income
- $-2,544,393 · -75.52%
- EPS
- $-0.12 · -71.43%
- Op Income
- $-2,545,803
- FCF YoY
- 50.22%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -33.06
- Avg Volume
- 161
Get TickerSpark's AI analysis on OVIT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our OVIT coverage
Recent articles, reports, and earnings notes.
No research on OVIT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OVIT report →Similar companies
Peers in the same neighborhood.